Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Cover

Acute Kidney Injury - Scientific Evidence Driving Change in Patient Management

Editor(s): Bellomo R. (Heidelberg, Vic.) 
Bonventre J. (Boston, Mass.) 

Status: available   
Publication year: 2008
Buy this book
Digital Version: CHF 45.00, EUR 42.00, USD 53.00
Print Version: CHF 45.00, EUR 42.00, USD 53.00
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.
Order this title

You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.



A review of recent clinical advances
The field of acute-care nephrology has recently seen significant changes, affecting the definition and classification of acute kidney dysfunction as well as our understanding of its epidemiology, the ability to make earlier diagnoses, the use of novel imaging modalities, and the insight into why acute kidney injury might occur under different clinical circumstances.
Different experts have contributed to this issue, emphasizing the importance of the change of concept from that of acute renal failure to that of acute kidney injury. This change has led to the development of new definitions and classifications which, together with the understanding that even minor subclinical injury to the kidney may matter, emphasize the need to develop early biomarkers. Sufficiently early diagnosis, a better classification system and a clearer understanding of the pathogenesis promise to deliver novel and effective therapies for patients.
Summarizing recent developments, this publication will be an indispensable help for the clinician to determine the best treatment options for his patients.